The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fleetwood, A. J.
Right arrow Articles by Cook, A. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fleetwood, A. J.
Right arrow Articles by Cook, A. D.
The Journal of Immunology, 2007, 178: 5245-5252.
Copyright © 2007 by The American Association of Immunologists, Inc.

Granulocyte-Macrophage Colony-Stimulating Factor (CSF) and Macrophage CSF-Dependent Macrophage Phenotypes Display Differences in Cytokine Profiles and Transcription Factor Activities: Implications for CSF Blockade in Inflammation1

Andrew J. Fleetwood2,*, Toby Lawrence{dagger}, John A. Hamilton* and Andrew D. Cook*

* Department of Medicine and Cooperative Research Centre for Chronic Inflammatory Diseases, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia; and {dagger} Kennedy Institute of Rheumatology Division, Imperial College London, Hammersmith, London, United Kingdom

GM-CSF and M-CSF (CSF-1) can enhance macrophage lineage numbers as well as modulate their differentiation and function. Of recent potential significance for the therapy of inflammatory/autoimmune diseases, their blockade in relevant animal models leads to a reduction in disease activity. What the critical actions are of these CSFs on macrophages during inflammatory reactions are unknown. To address this issue, adherent macrophages (GM-BMM and BMM) were first derived from murine bone marrow precursors by GM-CSF and M-CSF, respectively, and stimulated in vitro with LPS to measure secreted cytokine production, as well as NF-{kappa}B and AP-1 activities. GM-BMM preferentially produced TNF-{alpha}, IL-6, IL-12p70, and IL-23 whereas, conversely, BMM generated more IL-10 and CCL2; strikingly the latter population could not produce detectable IL-12p70 and IL-23. Following LPS stimulation, GM-BMM displayed rapid I{kappa}B{alpha} degradation, RelA nuclear translocation, and NF-{kappa}B DNA binding relative to BMM, as well as a faster and enhanced AP-1 activation. Each macrophage population was also pretreated with the other CSF before LPS stimulation and found to adopt the phenotype of the other population to some extent as judged by cytokine production and NF-{kappa}B activity. Thus, GM-CSF and M-CSF demonstrate, at the level of macrophage cytokine production, different and even competing responses with implications for their respective roles in inflammation, including a possible dampening or suppressive role for M-CSF in certain circumstances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 This work was supported by a grant and a Senior Principal Research Fellowship (to J.A.H.) from the National Health and Medical Research Council of Australia.

2 Address correspondence and reprint requests to Dr. Andrew J. Fleetwood, Department of Medicine and Cooperative Research Centre for Chronic Inflammatory Diseases, University of Melbourne, Royal Melbourne Hospital, Parkville, Victoria, Australia 3050. E-mail address: ajfleetwood{at}pgrad.unimelb.edu.au

3 Abbreviations used in this paper: DC, dendritic cell; BMM, M-CSF-dependent murine bone marrow-derived macrophage; GM-BMM, GM-CSF-dependent murine bone marrow-derived macrophage; M{phi}-1, proinflammatory type-1 human monocyte-derived subset; M{phi}-2, anti-inflammatory type-2 human monocyte-derived macrophage subset; Q-PCR, quantitative PCR.




This article has been cited by other articles:


Home page
J. Immunol.Home page
J. M. W. Quinn, N. A. Sims, H. Saleh, D. Mirosa, K. Thompson, S. Bouralexis, E. C. Walker, T. J. Martin, and M. T. Gillespie
IL-23 Inhibits Osteoclastogenesis Indirectly through Lymphocytes and Is Required for the Maintenance of Bone Mass in Mice
J. Immunol., October 15, 2008; 181(8): 5720 - 5729.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. Rosas, K. Liddiard, M. Kimberg, I. Faro-Trindade, J. U. McDonald, D. L. Williams, G. D. Brown, and P. R. Taylor
The Induction of Inflammation by Dectin-1 In Vivo Is Dependent on Myeloid Cell Programming and the Progression of Phagocytosis
J. Immunol., September 1, 2008; 181(5): 3549 - 3557.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. D. L. Savage, T. de Boer, K. V. Walburg, S. A. Joosten, K. van Meijgaarden, A. Geluk, and T. H. M. Ottenhoff
Human Anti-Inflammatory Macrophages Induce Foxp3+GITR+CD25+ Regulatory T Cells, Which Suppress via Membrane-Bound TGF{beta}-1
J. Immunol., August 1, 2008; 181(3): 2220 - 2226.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. L. Asquith, H. S. Ramshaw, P. M. Hansbro, K. W. Beagley, A. F. Lopez, and P. S. Foster
The IL-3/IL-5/GM-CSF Common Receptor Plays a Pivotal Role in the Regulation of Th2 Immunity and Allergic Airway Inflammation
J. Immunol., January 15, 2008; 180(2): 1199 - 1206.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2007 by The American Association of Immunologists, Inc. All rights reserved.